Skip to main content
Top
Published in: Archives of Virology 5/2024

01-05-2024 | Kaposi's Sarcoma-Associated Herpesvirus | Original Article

Analysis of the interaction between the ORF42 and ORF55 proteins encoded by Kaposi’s sarcoma-associated herpesvirus

Authors: Kazushi Kuriyama, Tadashi Watanabe, Shinji Ohno

Published in: Archives of Virology | Issue 5/2024

Login to get access

Abstract

Kaposi’s sarcoma-associated herpesvirus (KSHV) causes Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman disease. The tegument is a structure that is unique to herpesviruses that includes host and viral proteins, including the viral ORF42 and ORF55 proteins. Alphaherpesvirus tegument proteins have been well studied, but much is unknown regarding KSHV. Here, we report an interaction between the ORF42 and ORF55 proteins. ORF55 interacted with and recruited ORF42 from the nucleus to the cytoplasm. When ORF42 and ORF55 were expressed simultaneously in cultured cells, the expression level of these two viral proteins was higher than when either was expressed independently. ORF55, but not ORF42, was polyubiquitinated, suggesting that an unidentified regulatory mechanism may be present. A recombinant virus with an ectopic stop codon in ORF42 exhibited normal replication of genomic DNA, but fewer virus particles were released with the recombinant than with the wild-type virus. A unique R136Q mutation in ORF42, which is found in a KSHV strain that is prevalent on Miyako Island, Okinawa Prefecture, Japan, further increased the expression of ORF42 and ORF55 when these proteins were expressed simultaneously. However, the ORF42 R136Q mutation did not affect the localization pattern of ORF42 itself or of ORF55. In addition, experiments with a recombinant virus possessing the ORF42 R136Q mutation showed lower levels of production of the mutant virus than of the wild-type virus, despite similar levels of genome replication. We suggest that the R136Q mutation in ORF42 plays an important role in ORF55 protein expression and virus production.
Literature
1.
go back to reference Krug LT, Pellet PE (2022) The family Herpesviridae: A Brief introduction. In: Knipe DM, Howley PM, Damania BA, Cohen JI (eds) Fields Virology, vol 2, 7th edn. Lippincott Williams & Wilkins, pp 212–234 Krug LT, Pellet PE (2022) The family Herpesviridae: A Brief introduction. In: Knipe DM, Howley PM, Damania BA, Cohen JI (eds) Fields Virology, vol 2, 7th edn. Lippincott Williams & Wilkins, pp 212–234
5.
go back to reference Damania BA, Cesarman E (2022) Kaposi’s Sarcoma Herpesvirus. In: Knipe DM, Howley PM, Damania BA, Cohen JI (eds) Fields Virology, vol 2, 7th edn. Lippincott Williams & Wilkins, pp 513–572 Damania BA, Cesarman E (2022) Kaposi’s Sarcoma Herpesvirus. In: Knipe DM, Howley PM, Damania BA, Cohen JI (eds) Fields Virology, vol 2, 7th edn. Lippincott Williams & Wilkins, pp 513–572
6.
9.
go back to reference Arias C, Weisburd B, Stern-Ginossar N, Mercier A, Madrid AS, Bellare P, et al. KSHV 2.0: A Comprehensive Annotation of the Kaposi’s Sarcoma-Associated Herpesvirus Genome Using Next-Generation Sequencing Reveals Novel Genomic and Functional Features. PLoS Pathog 2014;10:1003847. https://doi.org/10.1371/journal.ppat.1003847. Arias C, Weisburd B, Stern-Ginossar N, Mercier A, Madrid AS, Bellare P, et al. KSHV 2.0: A Comprehensive Annotation of the Kaposi’s Sarcoma-Associated Herpesvirus Genome Using Next-Generation Sequencing Reveals Novel Genomic and Functional Features. PLoS Pathog 2014;10:1003847. https://​doi.​org/​10.​1371/​journal.​ppat.​1003847.
20.
go back to reference Watanabe T, Nishimura M, Izumi T, Kuriyama K, Iwaisako Y, Hosokawa K, et al. Kaposi’s Sarcoma-Associated Herpesvirus ORF66 Is Essential for Late Gene Expression and Virus Production via Interaction with ORF34. J Virol 2020;94. https://doi.org/10.1128/jvi.01300-19. Watanabe T, Nishimura M, Izumi T, Kuriyama K, Iwaisako Y, Hosokawa K, et al. Kaposi’s Sarcoma-Associated Herpesvirus ORF66 Is Essential for Late Gene Expression and Virus Production via Interaction with ORF34. J Virol 2020;94. https://​doi.​org/​10.​1128/​jvi.​01300-19.
28.
go back to reference Awazawa R, Utsumi D, Katano H, Awazawa T, Miyagi T, Hayashi K, et al. High Prevalence of Distinct Human Herpesvirus 8 Contributes to the High Incidence of Non-acquired Immune Deficiency Syndrome-Associated Kaposi’s Sarcoma in Isolated Japanese Islands. Journal of Infectious Diseases 2017;216:850–8. https://doi.org/10.1093/infdis/jix424. Awazawa R, Utsumi D, Katano H, Awazawa T, Miyagi T, Hayashi K, et al. High Prevalence of Distinct Human Herpesvirus 8 Contributes to the High Incidence of Non-acquired Immune Deficiency Syndrome-Associated Kaposi’s Sarcoma in Isolated Japanese Islands. Journal of Infectious Diseases 2017;216:850–8. https://​doi.​org/​10.​1093/​infdis/​jix424.
Metadata
Title
Analysis of the interaction between the ORF42 and ORF55 proteins encoded by Kaposi’s sarcoma-associated herpesvirus
Authors
Kazushi Kuriyama
Tadashi Watanabe
Shinji Ohno
Publication date
01-05-2024
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 5/2024
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-024-06021-7

Other articles of this Issue 5/2024

Archives of Virology 5/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.